[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroen
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-10-06 09:52:44 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S0140-6736(24)00701-3
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0140673624007013
其他信息:
出版社: Elsevier BV
作者: Simron Singh; Daniel Halperin; Sten Myrehaug; Ken Herrmann; Marianne Pavel; Pamela L Kunz; Beth Chasen; Salvatore Tafuto; Secondo Lastoria; Jaume Capdevila; Amparo García-Burillo; Do-Youn Oh; Changhoon Yoo; Thorvardur R Halfdanarson; Stephen Falk; Ilya Folitar; Yufen Zhang; Paola Aimone; Wouter W de Herder; Diego Ferone